Eating oranges daily may shift lipid patterns in fatty liver disease

Beyond the Plate: The Future of Fighting Fatty Liver with Precision Nutrition For decades, the medical advice for fatty liver disease was simple, if frustrating: “lose weight and eat better.” But as we move deeper into the era of personalized medicine, we are discovering that the fight against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is … Read more

Circulating exosomal microRNAs offer a non-invasive biomarker for MASLD

Moving Beyond Invasive Biopsies: The Rise of Liquid Biopsies in MASLD For years, diagnosing the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) often relied on invasive procedures. However, a shift toward non-invasive diagnostics is underway, driven by the discovery of circulating exosomal microRNAs. These tiny vesicles, released into the bloodstream, act as biological messengers … Read more

Liver cancer burden rising globally amid shift to metabolic risks

The Looming Liver Cancer Crisis: A Global Shift in Risk Factors Liver cancer remains a significant global health threat, ranking as the third leading cause of cancer-related deaths worldwide. In 2022 alone, nearly 870,000 new cases were reported, with hepatocellular carcinoma accounting for almost 80% of these. A concerning trend is emerging: even as progress … Read more

Satellite livers could provide booster function for patients awaiting transplants

Injectable “Satellite Livers”: A New Hope for Liver Failure Patients More than 10,000 Americans are currently on the waiting list for a liver transplant, a number that far exceeds the availability of donated organs. For many, the wait is a matter of life, and death. Now, a groundbreaking development from MIT engineers offers a potential … Read more

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

The Future of Metabolic Health: Beyond GLP-1, Towards Comprehensive Solutions A landmark review published in The Lancet confirms what many clinicians are witnessing: modern incretin-based drugs are fundamentally changing how we approach obesity, type 2 diabetes (T2D), and related health issues. But the story doesn’t end with semaglutide and tirzepatide. The research points towards a … Read more

Infant Formula Fats & Liver Health: New Study Reveals Potential Risks

Infant Formula and Liver Health: A Growing Concern for Parents and Researchers Novel research from Virginia Tech is shedding light on a potential link between certain fats in infant formula and the development of steatotic liver disease – formerly known as non-alcoholic fatty liver disease – in babies. While breast milk remains the gold standard, … Read more

New pathway found connecting liver congestion to fibrosis and cancer

Unlocking the Secrets of Liver Congestion: A New Pathway to Treatment Chronic liver congestion, a condition where blood pools in the liver, has long been recognized as a precursor to severe liver diseases like fibrosis and even cancer. However, the precise mechanisms driving this progression have remained elusive – until now. Researchers at The University … Read more

your parent’s body weight – WashU Medicine

The Generational Liver: How Parental Health is Rewriting the Rules of Liver Disease Risk For decades, liver disease has been largely understood as a consequence of lifestyle choices – diet, alcohol consumption, and viral infections. But a groundbreaking latest study from Washington University School of Medicine in St. Louis is challenging that narrative, revealing a … Read more

Expert guidance on fecal microbiota transplantation in liver disease

Fecal Microbiota Transplantation: A Gut Feeling About the Future of Liver Disease Treatment For decades, the gut has been seen as a digestive workhorse. Now, groundbreaking research is revealing its profound influence on nearly every aspect of our health, particularly liver function. Fecal Microbiota Transplantation (FMT) – the process of transferring fecal bacteria from a … Read more

New monoclonal antibody safe and effective for rare liver disease

Hope on the Horizon: New Treatment Offers Promise for Rare Liver Disease PSC A groundbreaking monoclonal antibody treatment, nebokitug, is offering a beacon of hope for individuals battling primary sclerosing cholangitis (PSC), a rare and debilitating liver disease. Recent Phase 2 trial results, published in the American Journal of Gastroenterology, demonstrate the safety and potential … Read more